The final regulatory wording for retatrutide including any warnings or precautions relating to thyroid disease has not yet been determined, as the medicine has not been approved
The Public Health Access Gap: Despite the expanding evidence pool, many individuals experiencing BED cannot access these medications through public healthcare systems, forcing patients to turn to private providers at substantial personal expense, a barrier the researchers hope this data will help dismantle
59 In recent years, it has been demonstrated that iron has become an independent factor affecting bone metabolic disorders, particularly in the context of iron overload in osteoporosis
Moreover, other routes of administration, such as intravenous, intranasal, and sublingual administration, can increase GSH levels [99]